| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/IJD.12834 |
| P698 | PubMed publication ID | 26108267 |
| P2093 | author name string | Zahra Amirghofran | |
| Basira Zandieh | |||
| Sahar Tahvili | |||
| P2860 | cites work | Circulating Th17, Th22, and Th1 cells are increased in psoriasis | Q24629315 |
| Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A | Q28216139 | ||
| Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis | Q33941199 | ||
| New insights of T cells in the pathogenesis of psoriasis | Q34043846 | ||
| Effective and sustainable biologic treatment of psoriasis: what can we learn from new clinical data? | Q34166896 | ||
| RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. | Q34660473 | ||
| The IL-23/Th17 axis in the immunopathogenesis of psoriasis | Q34969188 | ||
| Advances in the management of psoriasis: monoclonal antibody therapies | Q35030921 | ||
| The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. | Q35049530 | ||
| Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells | Q35441339 | ||
| Immune deviation strategies in the therapy of psoriasis | Q35793843 | ||
| Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis | Q37179608 | ||
| Type 17 T helper cells-origins, features and possible roles in rheumatic disease | Q37478061 | ||
| Th17 and Th22 cells in psoriatic arthritis and psoriasis | Q37689670 | ||
| The roles of cells and cytokines in the pathogenesis of psoriasis | Q37995658 | ||
| Targeting IL-17 in psoriasis: from cutaneous immunobiology to clinical application | Q38073592 | ||
| GM-CSF as a therapeutic target in inflammatory diseases | Q38128130 | ||
| Immunopathogenesis of psoriasis | Q40175802 | ||
| IL-1 alpha-induced expression of ICAM-1 on cultured hyperproliferative keratinocytes: suppression by antipsoriatic dimethyl-fumarate | Q41471610 | ||
| Fumaric acid esters in dermatology. | Q42401921 | ||
| IL-23 and Th17 cells in infections and psoriasis | Q44543574 | ||
| Th17 cells carrying TCR recognizing epidermal autoantigen induce psoriasis-like skin inflammation | Q44573746 | ||
| GM-CSF: the secret weapon in the T(H)17 arsenal | Q44887303 | ||
| Predominance of activated, clonally expanded T helper type 17 cells within the CD4+ T cell population in psoriatic lesions | Q46088131 | ||
| P433 | issue | 7 | |
| P304 | page(s) | e254-60 | |
| P577 | publication date | 2015-07-01 | |
| P1433 | published in | International Journal of Dermatology | Q15752742 |
| P1476 | title | The effect of dimethyl fumarate on gene expression and the level of cytokines related to different T helper cell subsets in peripheral blood mononuclear cells of patients with psoriasis | |
| P478 | volume | 54 |
| Q61449210 | Contribution of Nrf2 Modulation to the Mechanism of Action of Analgesic and Anti-inflammatory Drugs in Pre-clinical and Clinical Stages |
| Q46409637 | Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients. |
| Q92066922 | Dimethyl Fumarate Targets MSK1, RSK1, 2 and IKKα/β Kinases and Regulates NF-κB /p65 Activation in Psoriasis: A Demonstration of the Effect on Peripheral Blood Mononuclear Cells, Drawn from Two Patients with Severe Psoriasis Before and After Treatmen |
| Q39100528 | Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis |
| Q90577363 | Dimethyl fumarate is efficacious in severe plaque psoriasis : Post hoc analysis from the BRIDGE trial in Austria |
| Q64234795 | Modulation of proliferation and cytokine secretion of human lymphocytes by extracts |
| Q50141471 | Monomethyl fumarate treatment impairs maturation of human myeloid dendritic cells and their ability to activate T cells |
| Q57144024 | Mononuclear cell transcriptome changes associated with dimethyl fumarate in MS |
| Q64885022 | Therapeutic Potential of Ponesimod Alone and in Combination with Dimethyl Fumarate in Experimental Models of Multiple Sclerosis. |
Search more.